Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting

Canadian Journal of Anesthesia

Volumn 54, Issue 5, 2007, Pages 349-354

  Lee, Yi ^a   Wang, Po K ^a   Lai, Hsien Y ^a   Yang, Yao L ^a   Chu, Chin C ^b   Wang, Jhi Joung ^b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; METOCLOPRAMIDE; ONDANSETRON;

ADULT; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HUMAN; INCIDENCE; PAIN ASSESSMENT; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCORING SYSTEM; SEDATION;

EID: 34250176239     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022656     Document Type: Article

References (25)

1. Myles PS, Williams DL, Hendrata M, Anderson H, Weeks AM. Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth 2000; 84: 6-10.
2. Tramer MR. A rational approach to the control of postoperative nausea and vomiting: evidence from systemic reviews. Part II. Recommendations for prevention and treatment, and research agenda. Acta Anaesthesiol Scand 2001; 45: 14-9.
3. Gan TJ, White PF, Scuderi PE, Watcha MF, Kovac A. FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified? Anesthesiology 2002; 97: 287.
4. Mullins M, Van Zwieten K, Blunt JR. Unexpected cardiovascular deaths are rare with therapeutic doses of droperidol. Am J Emerg Med 2004; 22: 27-8.
5. Buttner M, Walder B, von Elm E, Tramer MR. Is lowdose haloperidol a usefiil antiemetic? A meta-analysis of published and unpublished randomized trials. Anesthesiology 2004; 101: 1454-63.
6. Vella-Brincat J, Macleod AD. Haloperidol in palliative care. Palliat Med 2004; 18: 195-201.
7. Apfel CC, Roewer N, Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiol Scand 2002; 46: 921-8.
8. Wang JJ, Ho ST, Lee SC, Liu YC, Ho CMI. The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study. Anesth Analg 2000; 91: 1404-7.
9. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol 1990; 10: 244-51.
10. Barton MD, Libonati M, Cohen PJ. The use of halo-peridol for treatment of postoperative nausea and vomiting - a double-blind placebo-controlled trial. Anesthesiology 1975; 42: 508-12.
11. Rusch D, Eberhart L, Biedler A, Dethling J, Apfel CC. Prospective application of a simplified risk score to prevent postoperative nausea and vomiting. Can J Anesth 2005; 52: 478-84.
12. Lerman J. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996, 43: 184-91.
13. Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg 1998; 86: 274-82.
14. Parlow JL, Costache J, Avery N, Turner K. Single-dose haloperidol for the prophylaxis of postoperative nausea and vomiting after intrathecal morphine. Anesth Analg 2004; 98: 1072-6.
15. Aouad MT, Siddik-Sayyid SM, Taha SK, et al. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. Eur J Anaesthesiol 2007; 24: 171-8.
16. Henzi I, Sonderegger J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anesth 2000; 47: 537-51.
17. Gan TJ, Meyer T, Apfel CC, et al.; Department of Anesthesiology, Duke University Medical Center. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71.
18. Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88: 659-68.
19. Perrault LP, Denault AY, Carrier M, Cartier R, Belisle S. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Can J Anesth 2000; 47: 251-4.
20. Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81: 238-40.
21. Benedict CR, Arbogast R, Martin L, Patton L, Morrill B, Hahne W. Single-blind study of the effects of intravenous dolasetron mesylate versus ondansetron on electrocardiographic parameters in normal volunteers. J Cardiovasc Pharmacol 1996; 28: 53-9.
22. Kasinath NS, Malak O, Tetzlaff J. Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. Can J Anesth 2003; 50: 229-31.
23. Baguley WA, Hay WT, Mackie KP, Cheney FW, Cullen BF. Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide. Anesth Analg 1997; 84: 1380-1.
24. Charbit B, Albaladejo P, Funck-Brentano C, Legrand M, Samain E, Marty J. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansmon. Anesthesiology 2005; 102: 1094-100.
25. White PF, Watcha MF. Are new drugs cost-effective for patients undergoing ambulatory surgery? Anesthesiology 1993; 78: 2-5.